Novel therapeutic targets in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) represents the most frequent lymphoma subtype and is considered a heterogeneous diagnostic category [1]. Using gene expression profiling, two major molecular subtypes termed germinal centre B-cell-like (GCB) DLBCL and activated B-cell-like (ABC) DLBCL can be dis...

Descripción completa

Detalles Bibliográficos
Autor principal: Lenz, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041475/
https://www.ncbi.nlm.nih.gov/pubmed/26217138
http://dx.doi.org/10.1016/j.ejcsup.2013.07.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041475/
https://www.ncbi.nlm.nih.gov/pubmed/26217138
http://dx.doi.org/10.1016/j.ejcsup.2013.07.041

Ejemplares similares